Fig 6. SATA-8505 Exhibits Commercial Viability but Significant Strain Limitations.
(a) SATA-8505 quantified over up to sixty days after storage at either room temperature (RT), 4 degrees Celsius (4°C), or frozen at -80°C. (b) Average hourly quantification of 108–109 CFU of USA100 S. aureus or a vancomycin resistant variant of USA100 (VRSA) cultured with up to 1011 PFU of SATA-8505. Data shown are a representative of 2 independent experiments.